Skip to main content
Prescription drug costs image by TaxRebate.org.uk via Flickr

The Case for a Public Option for the Drug Industry

Dana Brown

Dana Brown

Director of the Next System Project more

Isaiah J. Poole

Isaiah J. Poole

Editorial Manager, The Next System Project more

Health & Wellbeing

Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached a tentative settlement with some of the plaintiffs in which Purdue would transform itself through the bankruptcy process from a typical, profit-chasing drugmaker into a “public beneficiary company.” The proposition raises an important question: If plaintiffs are open to the idea of turning Purdue into a public trust run by appointees of a federal bankruptcy judge—one that would distribute its profits to state and local governments—why not take one more step? Why not create the beginnings of a network of public pharmaceutical companies like those that already exist in such countries as Sweden, Brazil, and Thailand?

Continue reading in The New Republic »

Dana Brown

Dana Brown

Director of the Next System Project more

Isaiah J. Poole

Isaiah J. Poole

Editorial Manager, The Next System Project more

More related work

Mylan/Viatris plant protest

The US is about to lose its largest generic pharmaceutical plant. It doesn’t have to.

We support a call on the Biden administration to use the Defense Production Act to keep the Viatris Morgantown, West Virginia drug plant open, and to adopt an industrial strategy that prioritizes public health over private greed. read more
All health is public health

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. read more